RT Journal Article
SR Electronic
T1 Managing Bell's palsy
JF Drug and Therapeutics Bulletin
JO Drug Ther Bull
FD BMJ Publishing Group Ltd
SP 49
OP 53
DO 10.1136/dtb.2006.44749
VO 44
IS 7
YR 2006
UL http://dtb.bmj.com/content/44/7/49.abstract
AB Each year in the UK, around 1 in 5,000 people develop Bell's palsy – a unilateral lower motor neurone facial weakness of rapid onset that can be physically and psychologically disabling.1 While around 71% of patients recover normal function of the facial muscles without treatment, 13% are left with slight weakness and 16% with moderate to severe weakness resulting in major facial dysfunction.2,3 People who recover usually do so quickly, with 85% of them reporting some improvement in the first 3 weeks.2 There is longstanding controversy about what, if any, treatment should be initiated for Bell's palsy. Here we discuss the management of patients with this condition.